SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2152221

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152221

Mammalian Cell Fermentation Technology Market Size, Share & Trends Analysis Report By Type, By Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Others), By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

The global mammalian cell fermentation technology market size was valued at USD 50.4 billion in 2025 and is projected to grow from USD 54.7 billion in 2026 to USD 97.8 billion in 2033, at a CAGR of 8.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.0% in 2025. Mammalian cells are commonly used to manufacture therapeutic proteins such as monoclonal antibodies, vaccines, and other biologics, along with several cell lines, including Chinese Hamster Ovary (CHO) cells, Human Embryonic Kidney (HEK) cells, and others. The increasing prevalence of chronic diseases, coupled with the growing demand for biologics, is fueling the demand for fermentation technologies.

By end-use, the CMOs & CDMOs segment dominated the market with a share of approximately 51.0% in 2025.

The market for mammalian cell fermentation technology is experiencing a significant surge due to the rising demand for biologics and biosimilars. These treatments have become crucial in managing various ailments, including cancer, autoimmune conditions, and infectious diseases. As pharmaceutical companies increasingly invest in developing new biologics, interest in mammalian cell fermentation technology continues to grow. For instance, in June 2025, WuXi Biologics announced plans to construct a new commercial biomanufacturing facility in Chengdu, China. The site will feature advanced biologics production capabilities, including a 15,000 L fermentation system with the potential for future expansion to 60,000 L, supporting the growing global demand for biologics and recombinant therapeutics. This investment highlights the increasing adoption of advanced cell culture and fermentation technologies to expand biologics manufacturing capacity worldwide.

Technological developments in cell culture are another driver boosting the market for mammalian cell fermentation. Higher yields of recombinant proteins and other biologics can now be achieved with serum-free media and advances in bioreactor technologies, which have fundamentally transformed the industry.

The market for mammalian cell fermentation technology has expanded due to the rise in chronic diseases such as diabetes, heart disease, and cancer. There is a constant need for mammalian cell fermentation tools because many illnesses necessitate long-term therapy, frequently with biologics. Overall, it is anticipated that the market for mammalian cell fermentation technology will expand over the next several years due to the ongoing need for biologics and biosimilars and advances in the treatment of chronic diseases.

Global Mammalian Cell Fermentation Technology Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global mammalian cell fermentation technology market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Billion, 2021 - 2033)

Chinese Hamster Ovary (CHO) Cell Fermentation

Human Embryonic Kidney (HEK) Cell Fermentation

Baby Hamster Kidney (BHK) Cell Fermentation

Murine Myeloma Cell Fermentation

Others

  • Application Outlook (Revenue, USD Billion, 2021 - 2033)

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Hormones

Enzymes

Others

  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)

Biopharmaceutical Companies

CMOs & CDMOs

Academic & Research Institutes

  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea

Latin America

    • Brazil
    • Mexico
    • Argentina

Middle East & Africa

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-071-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Demand for Biologics
    • 3.4.2. Increasing Investment in Research and Development of Novel Recombinant Proteins
    • 3.4.3. Increasing Focus on Personalized Medicine and Precision Medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost Associated with The Production of Biologics Using Mammalian Cell Fermentation Technology
    • 3.5.2. Regulatory Challenges
  • 3.6. Penetration And Growth Prospect Mapping 2025
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Mammalian Cell Fermentation Technology Market: Type Movement Analysis
  • 4.2. Chinese Hamster Ovary (CHO) Cell Fermentation
    • 4.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation Market, 2021 - 2033 (USD Billion)
  • 4.3. Human Embryonic Kidney (HEK) Cell Fermentation
    • 4.3.1. Human Embryonic Kidney (HEK) Cell Fermentation Market, 2021 - 2033 (USD Billion)
  • 4.4. Baby Hamster Kidney (BHK) Cell Fermentation
    • 4.4.1. Baby Hamster Kidney (BHK) Cell Fermentation Market, 2021 - 2033 (USD Billion)
  • 4.5. Murine Myeloma Cell Fermentation
    • 4.5.1. Murine Myeloma Cell Fermentation Market, 2021 - 2033 (USD Billion)
  • 4.6. Others
    • 4.6.1. Other Types Market, 2021 - 2033 (USD Billion)

Chapter 5. Application Business Analysis

  • 5.1. Monoclonal Antibodies
    • 5.1.1. Monoclonal Antibodies Market, 2021 - 2033 (USD Billion)
  • 5.2. Recombinant Proteins
    • 5.2.1. Recombinant Proteins Market, 2021 - 2033 (USD Billion)
  • 5.3. Vaccines
    • 5.3.1. Vaccines Market, 2021 - 2033 (USD Billion)
  • 5.4. Hormones
    • 5.4.1. Hormones Market, 2021 - 2033 (USD Billion)
  • 5.5. Enzymes
    • 5.5.1. Enzymes Market, 2021 - 2033 (USD Billion)
  • 5.6. Others
    • 5.6.1. Other Applications Market, 2021 - 2033 (USD Billion)

Chapter 6. End-Use Business Analysis

  • 6.1. Mammalian Cell Fermentation Technology Market: End-Use Movement Analysis
  • 6.2. Biopharmaceutical Companies
    • 6.2.1. Biopharmaceutical Companies Market, 2021 - 2033 (USD Billion)
  • 6.3. CMOs & CDMOs
    • 6.3.1. CMOs & CDMOs, Market, 2021 - 2033 (USD Billion)
  • 6.4. Academic And Research Institutes
    • 6.4.1. Academic And Research Institutes Market, 2021 - 2033 (USD Billion)

Chapter 7. Regional Business Analysis

  • 7.1. Mammalian Cell Fermentation Technology Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. U.S. Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Canada Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. UK Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Germany Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. France Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Italy Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Spain Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Denmark Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Sweden Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Norway Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Japan Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. China Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. India Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Australia Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Thailand Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. South Korea Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Brazil Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Mexico Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Argentina Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. South Africa Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Saudi Arabia Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. UAE Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Kuwait Mammalian Cell Fermentation Technology Market, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Danaher
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. F. Hoffmann-La Roche Ltd
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Sartorius AG
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. AstraZeneca
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Bristol-Myers Squibb
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Amgen
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Gilead Sciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
    • 8.4.11. Moderna, Inc
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Regeneron Pharmaceuticals
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-071-0

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 3 Global mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 4 Global mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 Global mammalian cell fermentation technology market, by region, 2018 - 2030 (USD Billion)
  • Table 6 North America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 8 North America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 9 North America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 10 U.S. mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 11 U.S. mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 12 U.S. mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 13 Canada mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 14 Canada mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 15 Canada mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 Europe mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
  • Table 17 Europe mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 18 Europe mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 19 Europe mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 UK mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 21 UK mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 22 UK mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 23 Germany mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Germany mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 25 Germany mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 France mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 27 France mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 28 France mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 Italy mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Italy mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 31 Italy mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 32 Spain mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 33 Spain mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 34 Spain mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 Denmark mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 36 Denmark mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 37 Denmark mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 38 Sweden mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 39 Sweden mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 40 Sweden mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Norway mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 42 Norway mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 43 Norway mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44 Asia Pacific mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
  • Table 45 Asia Pacific mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 46 Asia Pacific mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 47 Asia Pacific mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Japan mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Japan mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 50 Japan mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 51 China mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 52 China mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 53 China mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 54 India mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 55 India mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 56 India mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Australia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Australia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 59 Australia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60 Thailand mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 61 Thailand mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 62 Thailand mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63 South Korea mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 64 South Korea mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 65 South Korea mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66 Latin America mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
  • Table 67 Latin America mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 68 Latin America mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 69 Latin America mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70 Brazil mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 71 Brazil mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 72 Brazil mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 73 Mexico mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 74 Mexico mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 75 Mexico mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76 Argentina mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 77 Argentina mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 78 Argentina mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 79 Middle East & Africa mammalian cell fermentation technology market, by country, 2018 - 2030 (USD Billion)
  • Table 80 Middle East & Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD
  • Table 81 Middle East & Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 82 Middle East & Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 83 South Africa mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 84 South Africa mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 85 South Africa mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86 Saudi Arabia mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 87 Saudi Arabia mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89 UAE mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 90 UAE mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 91 UAE mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)
  • Table 92 Kuwait mammalian cell fermentation technology market, by type, 2018 - 2030 (USD Billion)
  • Table 93 Kuwait mammalian cell fermentation technology market, by application, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait mammalian cell fermentation technology market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Mammalian cell fermentation technology market segmentation
  • Fig. 8 Market snapshot, 2025
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2025
  • Fig. 15 Global mammalian cell fermentation technology market: Type movement analysis
  • Fig. 16 Global mammalian cell fermentation technology market, for Chinese Hamster Ovary (CHO) cell fermentation, 2021 - 2033 (USD Billion)
  • Fig. 17 Global mammalian cell fermentation technology market, for Human Embryonic Kidney (HEK) cell fermentation, 2021 - 2033 (USD Billion)
  • Fig. 18 Global mammalian cell fermentation technology market, for Baby Hamster Kidney (BHK) cell fermentation, 2021 - 2033 (USD Billion)
  • Fig. 19 Global mammalian cell fermentation technology market, for murine myeloma cell fermentation, 2021 - 2033 (USD Billion)
  • Fig. 20 Global mammalian cell fermentation technology market, for other types, 2021 - 2033 (USD Billion)
  • Fig. 21 Global mammalian cell fermentation technology market: Application movement analysis
  • Fig. 22 Global mammalian cell fermentation technology market, for monoclonal antibodies, 2021 - 2033 (USD Billion)
  • Fig. 23 Global mammalian cell fermentation technology market, for recombinant protein, 2021 - 2033 (USD Billion)
  • Fig. 24 Global mammalian cell fermentation technology market, for vaccines, 2021 - 2033 (USD Billion)
  • Fig. 25 Global mammalian cell fermentation technology market, for hormones, 2021 - 2033 (USD Billion)
  • Fig. 26 Global mammalian cell fermentation technology market, for enzymes, 2021 - 2033 (USD Billion)
  • Fig. 27 Global mammalian cell fermentation technology market, for other applications, 2021 - 2033 (USD Billion)
  • Fig. 28 Global mammalian cell fermentation technology market: End-use movement analysis
  • Fig. 29 Global mammalian cell fermentation technology market, for biopharmaceutical companies, 2021 - 2033 (USD Billion)
  • Fig. 30 Global mammalian cell fermentation technology market, for CMOs & CDMOs, 2021 - 2033 (USD Billion)
  • Fig. 31 Global mammalian cell fermentation technology market, for academic and research institutes, 2021-030, (USD Billion)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional outlook, 2025 & 2033
  • Fig. 34 Global mammalian cell fermentation technology market: Region movement analysis
  • Fig. 35 North America mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 36 U.S. mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 37 Canada mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 38 Europe mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 39 Germany mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 40 UK mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 41 France mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 42 Italy mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 43 Spain mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 44 Denmark mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 45 Sweden mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 46 Norway mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 47 Asia Pacific mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 48 Japan mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 49 China mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 50 India mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 51 Australia mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 52 South Korea mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 53 Thailand mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 54 Latin America mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 55 Brazil mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 56 Mexico mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 57 Argentina mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 58 Middle East and Africa mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 59 South Africa mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 60 Saudi Arabia mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 61 UAE mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
  • Fig. 62 Kuwait mammalian cell fermentation technology market, 2021 - 2033 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!